IGF2BP1 and cancer: As per the tumor-promotion role of IGF2BP1 in most of cancers, it seems that IGF2BP1 and its targeted transcripts could be attractive anticancer drug targets; however, small molecule inhibitors of IGF2BP1 and other cancer-related mRNA stabilizing proteins, as well as the upstream ncRNAs, are little known [8].